Search results
AstraZeneca Targets $80 Billion Revenue by 2030 Through Pipeline Expansion
The Wall Street Journal· 1 hour agoAstraZeneca has set out a new revenue target as it aims to bolster its investment in technologies...
AstraZeneca’s Revenue Target Signals Pipeline Momentum
The Wall Street Journal· 33 minutes agoNEWSPLUS 0729 GMT – AstraZeneca 2030 revenue target boosted by investment in 20 new drugs shows...
AstraZeneca aims for $80 billion in total revenue by 2030
Reuters via AOL· 2 hours agoCEO Pascal Soriot has rebuilt the company's pipeline of new drugs since taking the helm more than a...
FTSE 100 Live 21 May: AstraZeneca sets bold revenue target, index down
Evening Standard via Yahoo Finance· 10 minutes agoAccording to arch remainers, one of the many things that would go south if we left the EU was our...
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
Zacks via Yahoo Finance· 18 hours agoThis new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody...
European stocks fall in Fed rate concerns; AstraZeneca lifts revenue target
Investing.com· 3 hours agoEuropean stocks fall in Fed rate concerns; AstraZeneca lifts revenue target
Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient...
Benzinga via Yahoo Finance· 12 hours agoSunday, Amgen Inc (NASDAQ:AMGN) and AstraZeneca Plc (NASDAQ:AZN) announced the results of the Phase...
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga via Yahoo Finance· 12 hours agoA Delaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc...
From In-House at AstraZeneca to an E-discovery Startup: New Fileread GC Discusses Major Career Move...
Law.com· 13 hours agoThe fast evolution of artificial intelligence is spurring a new generation of legal tech...
AstraZeneca to build $1.5bn ADCs facility in Singapore
Investment Monitor via Yahoo Finance· 23 hours agoPharmaceutical giant AstraZeneca has announced plans to invest $1.5bn in a new antibody-drug...